Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.

Published on Aug 1, 2005in International Journal of Radiation Oncology Biology Physics5.859
· DOI :10.1016/J.IJROBP.2004.12.052
Carlos Vargas25
Estimated H-index: 25
(Beaumont Hospital),
Alvaro Martinez103
Estimated H-index: 103
(Beaumont Hospital)
+ 9 AuthorsJohn Wong78
Estimated H-index: 78
(Beaumont Hospital)
Purpose We analyzed our experience treating localized prostate cancer with image-guided off-line correction with adaptive high-dose radiotherapy (ART) in our Phase II dose escalation study to identify factors predictive of chronic rectal toxicity. Materials and Methods From 1999–2002, 331 patients with clinical stage T1-T3N0M0 prostate cancer were prospectively treated in our Phase II 3D conformal dose escalation ART study to a median dose of 75.6 Gy (range, 63.0–79.2 Gy), minimum dose to confidence limited-planning target volume (cl-PTV) in 1.8 Gy fractions (median isocenter dose=79.7 Gy). Seventy-four patients (22%) also received neoadjuvant/adjuvant androgen deprivation therapy. A patient-specific cl-PTV was constructed using 5 computed tomography scans and 4 sets of electronic portal images by applying an adaptive process to assure target accuracy and minimize PTV margin. For each case, the rectum (rectal solid) was contoured from the sacroiliac joints or rectosigmoid junction (whichever was higher) to the anal verge or ischial tuberosities (whichever was lower), with a median volume of 81.2 cc. The rectal wall was defined using the rectal solid with an individualized 3-mm wall thickness (median volume=29.8 cc). Rectal wall dose-volume histogram was used to determine the prescribed dose. Toxicity was quantified using the National Cancer Institute Common Toxicity Criteria 2.0. Multiple dose-volume endpoints were evaluated for their association with chronic rectal toxicity. Results Median follow-up was 1.6 years. Thirty-four patients (crude rate=10.3%) experienced Grade 2 chronic rectal toxicity at a median interval of 1.1 years. Nine patients (crude rate=2.7%) experienced Grade ≥3 chronic rectal toxicity (1 was Grade 4) at a median interval of 1.2 years. The 3-year rates of Grade ≥2 and Grade ≥3 chronic rectal toxicity were 20% and 4%, respectively. Acute toxicity predicted for chronic: Acute Grade 2–3 rectal toxicity ( p p = 0.02) and pain ( p = 0.008) were significant predictors of chronic Grade ≥2 rectal toxicity. Any acute rectal toxicity ( p = 0.001), any acute tenesmus ( p = 0.03), and any acute diarrhea ( p t test, linear regression) and when divided into subgroups (chi-square table). The chronic rectal toxicity Grade ≥2 risk was 9%, 18%, and 25% for the rectal wall relative V70 40% respectively. The volume of rectum or rectal wall radiated to ≥50 Gy was a strong predictor for chronic rectal toxicity. Nonpredictive factors: Rectal solid/wall absolute or relative volumes irradiated to ≤40 Gy, dose level, and use of androgen deprivation were not found predictive. Conclusions In our ART dose escalation study, rectal wall or rectum relative ≥V50 are closely predictive for chronic rectal toxicity. If rectal dose-volume histogram constraints are used to select the dose level, the risk of chronic rectal toxicity will reflect the risk of toxicity of the selected constraint rather than the dose selected as found in our study using an adaptive process. To select the prescribed dose, different dose-volume histogram constraints may be used including the rectal wall V70. Patients experiencing acute rectal toxicity are more likely to experience chronic toxicity.
📖 Papers frequently viewed together
281 Citations
320 Citations
1,210 Citations
#1Deborah A. Kuban (University of Texas MD Anderson Cancer Center)H-Index: 71
#2Lei Dong (University of Texas MD Anderson Cancer Center)H-Index: 73
The trend in prostate cancer radiation over the past several years has been to increase the dose to the gland while minimizing the dose to normal tissues. Intensity modulated radiation therapy is a computer-driven treatment planning and delivery system that has shown promise in improving disease-free outcome while decreasing the associated gastrointestinal and urinary complication rates. This technique continues to evolve, working toward image-guided radiation therapy, which is adjusted daily fo...
63 CitationsSource
Abstract Purpose To assess the rectal volume changes during radiotherapy for prostate cancer, to estimate an average rectal dose distribution profile during treatment, and to correlate these parameters with mild-to-moderate late rectal toxicity. Methods and materials Nine patients with localized prostate cancer underwent virtual CT simulation using a six-field conformal 18-MV photon technique. During treatment, patients underwent weekly pelvic CT scans under simulation conditions. Dosimetries we...
29 CitationsSource
#1Carlo Greco (IEO: European Institute of Oncology)H-Index: 18
#1Carlo Greco (IEO: European Institute of Oncology)H-Index: 5
Last. Roberto Orecchia (IEO: European Institute of Oncology)H-Index: 71
view all 7 authors...
Abstract Background and purpose : The rectum is known to display a dose–volume effect following high-dose 3D-conformal radiotherapy (3D-CRT). The aim of the study is to search for significant dose–volume combinations with the specific treatment technique and patient set-up currently used in our institution. Patients and methods : We retrospectively analyzed the dose–volume histograms (DVH) of 135 patients with stage T1b–T3b prostate cancer treated consecutively with 3D-CRT between 1996 and 2000 ...
85 CitationsSource
#1Patrick Cheung (U of T: University of Toronto)H-Index: 29
#2G. Morton (U of T: University of Toronto)H-Index: 12
Last. Jean-Philippe Pignol (U of T: University of Toronto)H-Index: 20
view all 8 authors...
1 CitationsSource
#1Alan Pollack (Fox Chase Cancer Center)H-Index: 83
#2A.L. Hanlon (Fox Chase Cancer Center)H-Index: 14
Last. Robert A. Price (Fox Chase Cancer Center)H-Index: 27
view all 6 authors...
The response of prostate cancer to radiation was well-documented in the pre-PSA era. Large palpable tumors resolved within months of treatment with relatively modest radiation doses of 64–70 Gy. The use of PSA-based failure as an endpoint, however, has made it clear that cure rates were much lower than appreciated. While doses in this range are still widely used today, data from retrospective, sequential prospective and now randomized studies indicate that for patients with intermediate-to-high ...
74 CitationsSource
#1Jeff M. Michalski (WashU: Washington University in St. Louis)H-Index: 73
#2Kathryn Winter (Radiation Therapy Oncology Group)H-Index: 66
Last. James D. Cox (University of Texas MD Anderson Cancer Center)H-Index: 91
view all 12 authors...
Abstract Purpose To evaluate the rates of low-grade late effects in patients treated for prostate cancer on Radiation Therapy Oncology Group (RTOG) 9406. Methods and materials Between August 1994 and September 1999, 424 patients were entered on this dose escalation trial of three-dimensional conformal radiation therapy (3D-CRT) for localized adenocarcinoma of the prostate at doses of 68.4 Gy (level I) and 73.8 Gy (level II). We have previously reported Grade 3 or greater late toxicity of patient...
65 CitationsSource
#1Colleen A. Lawton (MCW: Medical College of Wisconsin)H-Index: 61
Abstract Hormonal dependency of prostate cancer was first described in 1895 by White who showed the initial observation between castration and the treatment of prostatic disease in men with bladder outlet obstruction secondary to benign prostatic hypertrophy. Subsequently, in 1940 Huggins and Hodges demonstrated the association between normal and hyperplastic epithelium of canine prostate glands and adequate levels of circulating androgens. This pioneering work led extensive investigation of the...
10 CitationsSource
#1Eugene H. Huang (University of Texas MD Anderson Cancer Center)H-Index: 16
#2Alan Pollack (Fox Chase Cancer Center)H-Index: 83
Last. Deborah A. Kuban (University of Texas MD Anderson Cancer Center)H-Index: 71
view all 7 authors...
: To identify dosimetric, anatomic, and clinical factors that correlate with late rectal toxicity after three-dimensional conformal radiotherapy (3D-CRT) for prostate cancer. : We retrospectively analyzed the dose-volume histograms and clinical records of 163 Stage T1b-T3c prostate cancer patients treated between 1992 and 1999 with 3D-CRT, to a total isocenter dose of 74–78 Gy at The University of Texas M. D. Anderson Cancer Center. The median follow-up was 62 months (range 24–102). All late rec...
281 CitationsSource
#1Janice K. Ryu (UC Davis: University of California, Davis)H-Index: 11
#2Kathryn Winter (Radiation Therapy Oncology Group)H-Index: 66
Last. James D. Cox (University of Texas MD Anderson Cancer Center)H-Index: 91
view all 11 authors...
Abstract Purpose: A prospective Phase I dose escalation study was conducted to determine the maximally tolerated radiation dose in men treated with three-dimensional conformal radiotherapy (3D-CRT) for localized prostate cancer. This is a preliminary report of toxicity at Level III (79.2 Gy) on 3D Oncology Group/Radiation Therapy Oncology Group (RTOG) 9406. Methods and Materials: Between November 26, 1996 and October 1, 1998, 173 patients with clinically organ-confined prostate cancer (T1 and T2...
131 CitationsSource
#1J.M. Michalski (WashU: Washington University in St. Louis)H-Index: 14
#2Kathryn Winter (Radiation Therapy Oncology Group)H-Index: 66
Last. James D. Cox (University of Texas MD Anderson Cancer Center)H-Index: 91
view all 11 authors...
11 CitationsSource
Cited By193
Prostate cancer is one of the leading causes of cancer incidence among males worldwide. Radiotherapy can achieve similar oncological outcomes to those of radical prostatectomy. One concern is, however, radiation damage to the rectum because of the extreme proximity between the two organs. Inserting a biomaterial to separate the prostate and rectum is a promising strategy, and an injectable hydrogel is regarded to be the preferred spacer after screening of various materials. Nevertheless, there e...
#1Gaganpreet Singh (Panjab University, Chandigarh)H-Index: 2
#2Atul Tyagi (Memorial Hospital of South Bend)H-Index: 4
Last. Shelly Hukku (Memorial Hospital of South Bend)
view all 9 authors...
Introduction The present study aims to investigate the dosimetric and radiobiological impact of patient setup errors (PSE) on the target and organs at risk (OAR) of the cervix carcinoma stage IIB patients treated with volumetric-modulated arc therapy (VMAT) delivery technique using plan uncertainty parameters module of Varian Eclipse treatment planning system and in-house developed DVH Analyzer program. Materials and methods A total of 976 VMAT plans were generated to simulate the PSE in the bas...
#1Carri K Glide-Hurst (UW: University of Wisconsin-Madison)H-Index: 21
#2Percy Lee (University of Texas MD Anderson Cancer Center)H-Index: 6
Last. Evan WuthrickH-Index: 13
view all 16 authors...
The integration of adaptive radiation therapy (ART), or modifying the treatment plan during the treatment course, is becoming more widely available in clinical practice. ART offers strong potential for minimizing treatment-related toxicity while escalating or de-escalating target doses based on the dose to organs at risk. Yet, ART workflows add complexity into the radiation therapy planning and delivery process that may introduce additional uncertainties. This work sought to review presently ava...
4 CitationsSource
#1Yunze Yang (Mayo Clinic)H-Index: 1
#1Yunze Yang (Mayo Clinic)H-Index: 12
Last. Wei Liu (Mayo Clinic)H-Index: 22
view all 15 authors...
Abstract Purpose We proposed a novel tool of dose-linear-energy-transfer (LET) volume histogram (DLVH) and performed an exploratory study to investigate rectal bleeding in prostate cancer treated by intensity-modulated proton therapy (IMPT). Methods DLVH was constructed with dose and LET as two axes, while the normalized volume of the structure was contoured in the dose-LET plane as iso-volume lines. We defined DLVH index, DL v % ( d , l ), i.e., v % of the structure have a dose of ≥ d Gy and an...
Radiation therapy is an important ally when treating malignant lesions in the pelvic area, but it is not exempt of adverse events. There are some measures that can be taken to reduce the possibility of these effects, but some are non-modifiable factors related to previous treatments, location of the lesions or comorbidities. There is a wide variety of clinical presentations that can be of an acute or chronic onset that go from mild to severe forms or that can have a great impact in the quality o...
#1Daniel X. Yang (Yale University)H-Index: 3
#2Vivek Verma (Allegheny General Hospital)H-Index: 33
Last. Henry S. Park (Yale University)H-Index: 29
view all 7 authors...
Abstract Purpose Management options for localized prostate cancer include definitive radiation therapy (RT) or radical prostatectomy, with a subset of surgical patients requiring adjuvant or salvage RT after prostatectomy. The use of a peri-rectal hydrogel spacer in patients receiving definitive RT has been shown to reduce rectal doses and toxicity. However, in the postprostatectomy setting, a hydrogel spacer cannot be routinely placed. Therefore, we sought to compare rectal dosimetry between de...
#1Owen Paetkau (UVic: University of Victoria)H-Index: 1
#2Isabelle M. Gagne (UVic: University of Victoria)H-Index: 3
Last. Abraham Alexander (UBC: University of British Columbia)H-Index: 5
view all 3 authors...
Prostate cancer external beam radiation therapy can result in toxicity due to organ at risk (OAR) dose, potentially impairing quality of life. A polyethylene glycol-based spacer, SpaceOAR(c) hydrogel (SOH), implanted between prostate gland and rectum may significantly reduce dose received by the rectum and hence risk of rectal toxicity. SOH implant is not equally effective in all patients. Determining patients in which the implant will offer most benefit, in terms of rectal dose reduction, allow...
#1Yosuke TakakusagiH-Index: 6
#2Hiroyuki KatohH-Index: 17
Last. Tadashi KamadaH-Index: 50
view all 9 authors...
Carbon-ion radiotherapy (CIRT) for prostate cancer was initiated at Kanagawa Cancer Center in 2015. The present study analyzed the preliminary clinical outcomes of CIRT for prostate cancer. The clinical outcomes of 253 patients with prostate cancer who were treated with CIRT delivered using the spot scanning method between December 2015 and December 2017 were retrospectively analyzed. The irradiation dose was set at 51.6 Gy (relative biological effectiveness) delivered in 12 fractions over 3 wee...
10 CitationsSource
#1Adeleh SahebnasaghH-Index: 6
#2Arash Ghasemi (Mazandaran University of Medical Sciences)H-Index: 8
Last. Ebrahim Salehifar (Mazandaran University of Medical Sciences)H-Index: 15
view all 8 authors...
BACKGROUND: Acute radiation-induced proctitis (ARP) is the most common side effect following radiotherapy for malignant pelvic disease. This study evaluated the efficacy of Aloe vera ointment in prevention of ARP. METHODS: Forty-two patients receiving external-beam radiotherapy (RT) for pelvic malignancies were randomized to receive either Aloe vera 3% or placebo topical ointment during radiotherapy for 6 weeks. These patients were evaluated based on the severity (grade 0-4) of the following sym...
3 CitationsSource
#1Yawen Zheng (UM: University of Michigan)H-Index: 1
#2Wei Gao (Academy of Medical Sciences, United Kingdom)H-Index: 1
Last. Ligang Xing (Academy of Medical Sciences, United Kingdom)H-Index: 1
view all 5 authors...
Perforation of gastrointestinal (GI) tract is a rare, but serious complication of abdominopelvic irradiation, and it can even occur several years after radiotherapy. As one of the symptoms of radiation enteropathy, it shares common features with other chronic complications and has its own characteristic at the same time. It has been reported that some systematic therapies, such as sorafenib and bevacizumab, could add the risk of radiation-induced GI perforation. The potential mechanisms of aggra...
5 CitationsSource